RCMI Coordinating Center (RCMI CC) Header Logo

Connection

James Lillard to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications James Lillard has written about Xenograft Model Antitumor Assays.
James Lillard
Connection Strength
0.077
Xenograft Model Antitumor Assays
  1. Singh S, Bond VC, Powell M, Singh UP, Bumpers HL, Grizzle WE, Lillard JW. CXCR4-gp120-IIIB interactions induce caspase-mediated apoptosis of prostate cancer cells and inhibit tumor growth. Mol Cancer Ther. 2009 Jan; 8(1):178-84.
    View in: PubMed
    Score: 0.077
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support